Search results for "myocardial infarction."

showing 10 items of 1011 documents

Risk Stratification Using the CHA(2)DS(2)-VASc Score in Takotsubo Syndrome: Data From the Takotsubo Italian Network

2017

Background The CHA 2 DS 2 ‐VASc score predicts stroke in patients with atrial fibrillation and has been reported to have a prognostic role even in acute coronary syndrome patients. The Takotsubo syndrome is a condition that mimics acute coronary syndrome and may present several complications including stroke. We sought to assess the ability of CHA 2 DS 2 ‐VASc score to predict adverse events in Takotsubo syndrome patients. Methods and Results Overall, 371 Takotsubo syndrome patients were enrolled in a prospective registry. Patients were divided into 3 groups according to the CHA 2 DS 2 ‐VASc score: Group A (≤1), B (2–3), and C (≥4). The median CHA 2 DS 2 ‐VASc score was 3 (interquartile ra…

MalePediatricsArrhythmias030204 cardiovascular system & hematologySeverity of Illness Index0302 clinical medicineRisk FactorsInterquartile rangeOdds RatioCoronary Heart DiseaseProspective StudiesRegistries030212 general & internal medicineMyocardial infarctionDSStrokeTakotsuboOriginal ResearchIncidenceMortality rateanticoagulant cardiovascular events CHA2DS2-VASc score stroke Takotsubo Takotsubo cardiomyopathy. Takotsubo syndromeAtrial fibrillationMiddle AgedPrognosisAnticoagulant; Cardiovascular events; CHA2DS2-VASc score; Stroke; Takotsubo; Takotsubo cardiomyopathy; Takotsubo syndrome; Cardiology and Cardiovascular MedicineStrokeItalyCardiologyFemaleCHA2DS2‐VASc scoreTakotsubo syndromeCardiology and Cardiovascular Medicinemedicine.medical_specialtyAcute coronary syndromeCHA2DS2-VASc scoreCardiomyopathy2Cardiovascular eventRisk Assessment-VASc scorecardiovascular events03 medical and health sciencesInternal medicinemedicineHumansAgedbusiness.industryAnticoagulantAnticoagulantsThrombosisOdds ratiomedicine.diseaseCHA2DS2–VASc scoreCHACerebrovascular Disease/StrokeTakotsubo cardiomyopathybusinessFollow-Up Studies
researchProduct

GDF-15 predicts cardiovascular events in acute chest pain patients

2017

Background Treatment of patients presenting with possible acute myocardial infarction (AMI) is based on timely diagnosis and proper risk stratification aided by biomarkers. We aimed at evaluating the predictive value of GDF-15 in patients presenting with symptoms suggestive of AMI. Methods Consecutive patients presenting with suspected AMI were enrolled in three study centers. Cardiovascular events were assessed during a follow-up period of 6 months with a combined endpoint of death or MI. Results From the 1818 enrolled patients (m/f = 1208/610), 413 (22.7%) had an acute MI and 63 patients reached the combined endpoint. Patients with MI and patients with adverse outcome had higher GDF-15 le…

MalePhysiologyPeptide HormonesMyocardial InfarctionSocial Scienceslcsh:MedicineKaplan-Meier Estimate030204 cardiovascular system & hematologyChest painSeverity of Illness IndexBiochemistryVascular Medicine0302 clinical medicineRisk FactorsMedicine and Health SciencesCoronary Heart Disease030212 general & internal medicineMyocardial infarctionlcsh:ScienceMultidisciplinarybiologyHazard ratioMiddle AgedTroponinLipoproteins LDLAcute DiseaseFemalemedicine.symptomLipoproteins HDLResearch ArticleGlomerular Filtration Ratemedicine.medical_specialtyChest PainGrowth Differentiation Factor 15LipoproteinsCardiologyRenal functionPhonology03 medical and health sciencesNatriuretic PeptideInternal medicineSeverity of illnessmedicineHumansSyntaxddc:610AgedProportional Hazards ModelsRenal PhysiologyProportional hazards modelbusiness.industryTroponin Ilcsh:RBiology and Life SciencesProteinsLinguisticsmedicine.diseaseTroponinHormonesSurgeryCytoskeletal Proteinsbiology.proteinlcsh:QGDF15businessBiomarkers
researchProduct

Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk

2015

Abstract— Elevated systolic blood pressure (SBP) correlates to cognitive decline and incident dementia. The effects of heart rate (HR), visit to visit HR variation, and visit to visit SBP variation are less well established. Patients without preexisting cognitive dysfunction (N=24 593) were evaluated according to mean SBP, SBP visit to visit variation (coefficient of variation [standard deviation/mean×100%], CV), mean HR, and visit to visit HR variation (HR-CV) in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease. Cognitive function was assessed with min…

MalePredictive Value of TestAngiotensin-Converting Enzyme InhibitorsBlood PressureBenzimidazoleBenzoatesRamiprilRetrospective StudieHeart RateRisk FactorsCardiovascular DiseaseTelmisartanCognitive declineMultivariate AnalysiRandomized Controlled Trials as TopicAged 80 and overmedicine.diagnostic_testIncidenceMiddle AgedstrokeAntihypertensive Agentmyocardial infarctionCardiovascular DiseasesHypertensionCardiologyDrug Therapy CombinationFemaleHumanmedicine.drugRamiprilmedicine.medical_specialtyBenzoateFollow-Up StudieCognition DisorderPredictive Value of TestsInternal medicineHeart rateInternal MedicinemedicineHumansDementiaAntihypertensive AgentsAgedRetrospective StudiesMini–Mental State Examinationbusiness.industryRisk FactorAngiotensin-Converting Enzyme InhibitorOdds ratiomedicine.diseaseConfidence intervalBlood pressureMultivariate AnalysisPhysical therapyBenzimidazolesCognition DisordersbusinessFollow-Up StudiesHypertension
researchProduct

Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwentsurgical reperfusion: a randomized double-…

2007

Background: The inflammatory cascade has been hypothesized to be an important mechanism of post-ischaemic myocardial reperfusion injury and several studies demonstrated that C1 esterase inhibitor (C1 -INH) is effective in post-ischaemia myocardial protection. Therefore, we aimed to investigate prospectively in a randomised double-blind study the cardioprotective effects of C1-INH in ST segment elevation myocardial infarction (STEMI) in patients who underwent emergent reperfusion with coronary artery bypass grafting (CABG). Methods: In this study, we enrolled 80 patients affected with STEMI who underwent emergent CABG. Patients were assigned in two groups (C1-INH group: receive 1000 Ul of C1…

MalePulmonary and Respiratory MedicineCardiac function curvemedicine.medical_specialtyMean arterial pressureCardiotonic AgentsMyocardial InfarctionCardiac indexMyocardial ReperfusionComplement C1 Inactivator ProteinsCoronary artery bypass surgeryReperfusion therapyDouble-Blind MethodInternal medicinemedicineHumansProspective StudiesMyocardial infarctionCoronary Artery BypassInfusions IntravenousSTEMI patients CABG C1 esterase inhibitor Reperfusion injury Complement cascade Myocardial function recoverybusiness.industryST elevationTroponin IComplement C4aGeneral MedicineMiddle Agedmedicine.diseaseMyocardial ContractionComplement Inactivating AgentsTreatment OutcomeComplement C3aCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessReperfusion injury
researchProduct

Off-pump versus on-pump myocardial revascularization in patients with ST-segment elevation myocardial infarction: A randomized trial

2009

Objective Conventional cardioplegic arrest coronary artery bypass grafting after ST-segment elevation myocardial infarction is associated with high mortality and morbidity. The benefits of off-pump surgery have been suggested. This study randomly evaluated the impact of the off-pump technique on clinical results. Methods Between February 2002 and October 2007, 128 patients with ST-segment elevation myocardial infarction who underwent myocardial revascularization within 48 hours from the onset of symptoms were randomly assigned to 2 groups: on-pump group (66 patients/51.5%) and off-pump group (63 patients/48.5%). The primary end point was the incidence of in-hospital death and outcomes (low …

MalePulmonary and Respiratory MedicineCardiac function curvemedicine.medical_specialtyTime FactorsOff-pump myocardial revascularization on-pump myocardial revascularization ST-segment elevation myocardial infarctionmedicine.medical_treatmentCoronary Artery Bypass Off-PumpMyocardial Infarctionlaw.inventionlawInternal medicineMyocardial RevascularizationCardiopulmonary bypassHumansMedicineMyocardial infarctionAgedbusiness.industryCardiogenic shockST elevationPercutaneous coronary interventionPerioperativeMiddle Agedmedicine.diseaseIntensive care unitCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

Bridge to Operation with the GPIIb/IIIa Inhibitor Abciximab in High-Risk Coronary Patients

2006

BACKGROUND Glycoprotein-IIb/IIIa inhibitors are now frequently used in the cardiological treatment of high-risk coronary patients even if the patient is considered suitable for surgical intervention. However, there is no consensus whether GPIIb/IIIa inhibitors should be stopped before operation because of an increased risk of bleeding or if surgery should even be delayed until the anticoagulating effect subsides. METHODS From June 2002 to August 2003 140 patients who had to undergo primary aorto-coronary bypass for ongoing myocardial ischemia were enrolled in the present study. The patients received either clopidogrel, aspirin and heparin or additionally abciximab until operation. RESULTS A…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyAbciximabMyocardial InfarctionHemodynamicsCoronary DiseasePlatelet Glycoprotein GPIIb-IIIa ComplexImmunoglobulin Fab FragmentsGpIIb/IIIaRisk FactorsInternal medicinemedicineAbciximabHumansProspective StudiesRegistriesCoronary Artery BypassAgedAspirinbusiness.industryIncidence (epidemiology)Antibodies MonoclonalHeparinMiddle AgedClopidogrelSurvival AnalysisHemostasis SurgicalTreatment OutcomeBridge (graph theory)Elective Surgical ProceduresCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessBiomarkersPlatelet Aggregation InhibitorsFollow-Up Studiesmedicine.drugThe Thoracic and Cardiovascular Surgeon
researchProduct

Extrathoracic Arteriosclerotic Vascular Changes Preclude the Use of the Internal Thoracic Artery for Coronary Artery Bypass Grafting

1996

During a two-years period we have treated 6 patients where use of the internal thoracic artery for coronary artery grafting was precluded because of extrathoracic arteriosclerotic vascular lesions. In four patients with severe aorto-iliac occlusive disease preoperative digital angiography demonstrated collateralisation of the lower extremity by either the left, right, or both internal thoracic arteries (ITA). In these cases use of the ITA was excluded in order to preserve the collateral supply and coronary bypass grafting was performed using only saphenous vein. In two patients with proximal occlusion of the left subclavian artery the right ITA was used as in-situ bypass to graft the left a…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyBypass graftingOcclusive diseaseCollateral CirculationCoronary Artery DiseaseInternal thoracic arteryPostoperative ComplicationsThoracic ArteriesIschemiaRisk FactorsInternal medicinemedicine.arteryOcclusionmedicineHumansSaphenous VeinMyocardial infarctionCoronary Artery BypassVeinAgedLegbusiness.industryAngiography Digital SubtractionPerioperativemedicine.diseasemedicine.anatomical_structureCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessArteryThe Thoracic and Cardiovascular Surgeon
researchProduct

Troponin T — a reliable marker of perioperative myocardial infarction?

1993

Following cardiac surgery, electrocardiography and creatine kinase isoenzyme MB (CK-MB) activities are of limited value in diagnosing a non-transmural infarction. With the recent availability of an assay to detect serial levels of the specific cardiocyte contractile protein troponin T the possibility has been increased of closing a diagnostic gap among cardiosurgical patients. Ninety patients with severe diffuse three-vessel disease undergoing myocardial revascularization were grouped by their postoperative electrocardiographic (ECG) findings (group I--unchanged ECG; group II--new Q-waves representing perioperative myocardial infarction (PMI)). Serial levels of troponin T and the activity o…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyMicrogramMyocardial InfarctionInfarctionCoronary DiseaseSensitivity and SpecificityElectrocardiographyPostoperative ComplicationsTroponin TPredictive Value of TestsInternal medicinemedicineHumansMyocardial infarctionCreatine KinaseAgedBundle branch blockmedicine.diagnostic_testbiologyTroponin Tbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseTroponinTroponinIsoenzymesQuartileCardiologybiology.proteinFemaleSurgeryCardiology and Cardiovascular MedicinebusinessElectrocardiographyBiomarkersEuropean Journal of Cardio-Thoracic Surgery
researchProduct

Prognostic value of fragmented QRS on a 12-lead ECG in patients with acute myocardial infarction

2013

Abstract Objective To investigate the determinants and the prognostic value of fragmented QRS (fQRS) after AMI. Patients and methods Prospective cohort of 307 consecutive patients with AMI. Main outcomes measured MACE (death plus non-fatal recurrent MI), hospitalization for an episode of heart failure, ventricular arrhythmia (VT or VF) at two years follow-up. Results On the serial 12-lead ECG recorded during the in-hospital stay, 162 (53%) had no fQRS ( no fQRS group ). 145 (47%) presented an fQRS, which was persistent in 108 (34%) patients ( persistent fQRS group ) and transient in 37 (12%) patients ( transient fQRS group ). Patients with a fragmented QRS (transient or persistent) were old…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyMyocardial InfarctionCritical Care and Intensive Care MedicineCoronary artery diseaseElectrocardiographyRecurrenceInternal medicinemedicineHumansProspective Studiescardiovascular diseasesMyocardial infarctionProspective cohort studyAgedHeart FailureUnivariate analysisEjection fractionProportional hazards modelbusiness.industryArrhythmias CardiacMiddle AgedPrognosismedicine.diseaseSurvival AnalysisLogistic ModelsHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessMaceHeart & Lung
researchProduct

Diagnosis of perioperative myocardial necrosis following coronary artery surgery — a reappraisal of isoenzyme analysis

1990

Although the routine determination of CK-MB activity is widely used after coronary artery bypass grafting (CABG), the diagnosis of a perioperative myocardial necrosis remains arbitrary. The intention of the present study was to develop discriminative enzymatic parameters of CK-MB activity in a collective of 710 patients following CABG. Patients were grouped according to their postoperative electrocardiogram (ECG). For each patient, the time activity curve of CK-MB was determined. The total amount of CK-MB was calculated by integrating the area beneath the CK-MB activity curve. Patients presenting with an unchanged postoperative ECG (group I) or a new bundle branch block with uncompromised h…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyPercentileCardiac outputMyocardial InfarctionHemodynamicsElectrocardiographyInternal medicinemedicineHumansDerivationCoronary Artery BypassIntraoperative ComplicationsCreatine KinaseBundle branch blockbiologybusiness.industryHemodynamicsStroke VolumeGeneral MedicinePerioperativeMiddle AgedPrognosismedicine.diseaseIsoenzymesmedicine.anatomical_structureAnesthesiaCardiologybiology.proteinFemaleSurgeryCreatine kinaseCardiology and Cardiovascular MedicinebusinessArteryEuropean Journal of Cardio-Thoracic Surgery
researchProduct